|
EP1021179B1
(en)
|
1997-02-04 |
2004-05-12 |
Murray A. Johnstone |
Method of enhancing hair growth
|
|
ATE281432T1
(de)
|
1999-03-05 |
2004-11-15 |
Univ Duke |
C-16 ungesätigte fp-selektive prostaglandin analoge
|
|
US6894175B1
(en)
|
1999-08-04 |
2005-05-17 |
The Procter & Gamble Company |
2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
|
|
JP4162823B2
(ja)
*
|
2000-01-07 |
2008-10-08 |
花王株式会社 |
頭髪用化粧料
|
|
US6579542B1
(en)
*
|
2000-03-02 |
2003-06-17 |
Cecil Faulkner |
Treating feline-specific disorders by orally administering Hydrastis canadensis
|
|
US20020013294A1
(en)
*
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
US20020172693A1
(en)
*
|
2000-03-31 |
2002-11-21 |
Delong Michell Anthony |
Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
|
|
US20020037914A1
(en)
*
|
2000-03-31 |
2002-03-28 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
|
|
US20020146439A1
(en)
*
|
2000-03-31 |
2002-10-10 |
Delong Mitchell Anthony |
Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
|
|
FR2812191B1
(fr)
*
|
2000-07-28 |
2003-10-17 |
Oreal |
Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
FR2812192B1
(fr)
*
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
|
FR2812193B1
(fr)
*
|
2000-07-28 |
2003-10-24 |
Oreal |
Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
|
|
FR2812190B1
(fr)
*
|
2000-07-28 |
2003-01-31 |
Oreal |
Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
|
|
WO2003009820A2
(en)
*
|
2001-07-25 |
2003-02-06 |
Alcon, Inc. |
Methods for promotion of hair growth comprising topical application of prostaglandin analogues
|
|
AU2012261499B2
(en)
*
|
2002-02-04 |
2016-05-12 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
|
US7351404B2
(en)
*
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
|
JP4340545B2
(ja)
*
|
2002-04-23 |
2009-10-07 |
ロレアル |
毛髪の成長を促進し及び／又は抜毛を防止又は遅延化するための化粧品組成物
|
|
US7320967B2
(en)
*
|
2002-04-23 |
2008-01-22 |
L'oreal |
Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
|
|
US20030199590A1
(en)
*
|
2002-07-25 |
2003-10-23 |
Cagle Gerald D |
Prostaglandin analogues for promotion of hair growth
|
|
US20040115234A1
(en)
*
|
2002-09-24 |
2004-06-17 |
Gewirtz Joan T. |
Cosmetic composition
|
|
US7326717B2
(en)
|
2003-05-06 |
2008-02-05 |
L'oreal |
Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
|
|
TWI348386B
(en)
*
|
2003-08-12 |
2011-09-11 |
R Tech Ueno Ltd |
Composition and method for promoting hair growth
|
|
US20050058614A1
(en)
*
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
|
|
WO2006070942A1
(en)
*
|
2004-12-29 |
2006-07-06 |
R-Tech Ueno, Ltd |
Composition and method for scalp and hair treatment
|
|
CN101160114B
(zh)
*
|
2004-12-29 |
2013-02-06 |
株式会社·R-技术上野 |
头皮和毛发处理组合物及方法
|
|
US20060177403A1
(en)
*
|
2005-02-08 |
2006-08-10 |
L'oreal |
Cosmetic/dermatological compositions comprising a derivative of glucose and of vitamin
F and A specific surfactant
|
|
US20070009468A1
(en)
*
|
2005-05-12 |
2007-01-11 |
Bernstein Eric F |
Photodynamic method of inducing the growth of hair
|
|
WO2007023841A1
(ja)
*
|
2005-08-25 |
2007-03-01 |
Taisho Pharmaceutical Co., Ltd. |
発毛剤組成物
|
|
WO2007111806A2
(en)
|
2006-03-23 |
2007-10-04 |
Massachusetts Eye And Ear Infirmary |
Cyclopentane heptanoic acid compounds for reducing body fat
|
|
US7879910B1
(en)
|
2006-10-10 |
2011-02-01 |
Jan Marini Skin Research, Inc. |
Compositions and methods for promoting lush hair growth
|
|
FR2916350B1
(fr)
*
|
2007-05-22 |
2009-07-24 |
Oreal |
Utilisation d'agonistes du recepteur du thromboxame pour moduler la croissance pilaire
|
|
US20090018204A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Brinkenhoff Michael C |
Composition and method for enhancing hair growth
|
|
FR2920309B1
(fr)
|
2007-08-28 |
2010-05-28 |
Galderma Res & Dev |
Utilisation de travoprost pour traiter la chute des cheveux
|
|
WO2010039535A1
(en)
*
|
2008-09-23 |
2010-04-08 |
Meta Cosmetics, Llc |
Compositions and methods to treat epithelial-related conditions
|
|
US7632867B2
(en)
*
|
2007-10-31 |
2009-12-15 |
Meta Cosmetics, Llc |
Prostaglandin analog compositions to treat epithelial-related conditions
|
|
US8455547B2
(en)
*
|
2008-02-05 |
2013-06-04 |
Allergan, Inc. |
Substituted cyclopentanes having prostaglandin activity
|
|
US7964596B2
(en)
*
|
2008-03-07 |
2011-06-21 |
Allergan, Inc. |
Therapeutic compounds
|
|
AU2009246330B2
(en)
|
2008-05-14 |
2015-04-02 |
Peter Thomas Roth Labs, Llc |
Prostaglandin based compositions and method of use thereof
|
|
US20080275118A1
(en)
*
|
2008-06-12 |
2008-11-06 |
Shaw Mari M |
Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss
|
|
WO2010027040A1
(ja)
*
|
2008-09-04 |
2010-03-11 |
参天製薬株式会社 |
１５，１５－ジフルオロプロスタグランジンＦ2α誘導体を有効成分として含有する毛髪成長促進剤
|
|
US8722739B2
(en)
|
2008-10-29 |
2014-05-13 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US8623918B2
(en)
*
|
2008-10-29 |
2014-01-07 |
Novaer Holdings, Inc. |
Amino acid salts of prostaglandins
|
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
|
WO2010064203A1
(en)
|
2008-12-02 |
2010-06-10 |
L'oreal |
Combination of reduced glutathione and amino acids for improving the quality of the hair in women
|
|
FR2941150B1
(fr)
*
|
2009-01-16 |
2013-01-11 |
Oreal |
Produit pour la prevention ou le traitement du blanchissement des cheveux.
|
|
US20110293549A1
(en)
|
2009-02-03 |
2011-12-01 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
|
WO2010138422A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Allergan, Inc. |
Cyclosporin derivatives for enhancing the growth of hair
|
|
FR2949052B1
(fr)
|
2009-08-13 |
2015-03-27 |
Oreal |
Procede de traitement cosmetique du cuir chevelu.
|
|
DK2498783T3
(en)
|
2009-11-09 |
2018-12-10 |
Allergan Inc |
COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
|
|
EP2498784A2
(en)
*
|
2009-11-09 |
2012-09-19 |
Allergan, Inc. |
Compositions for enhancing hair growth
|
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
|
WO2012018324A1
(en)
|
2010-08-02 |
2012-02-09 |
Athena Cosmetics, Inc. |
Composition, method and kit for enhancing hair
|
|
AU2011338530B2
(en)
*
|
2010-12-06 |
2017-06-15 |
Follica, Inc. |
Methods for treating baldness and promoting hair growth
|
|
EP3378480A1
(en)
|
2011-01-19 |
2018-09-26 |
Topokine Therapeutics, Inc. |
Methods and compositions for treating obesity
|
|
US8859616B2
(en)
*
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
|
KR101623132B1
(ko)
|
2011-06-08 |
2016-05-20 |
에스케이케미칼주식회사 |
속눈썹 성장용 조성물
|
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
|
DK2838533T3
(da)
|
2012-04-16 |
2017-11-27 |
Univ Case Western Reserve |
Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
|
|
CA2874288A1
(en)
*
|
2012-05-30 |
2013-12-05 |
Asahi Glass Company, Limited |
Composition for hair growth
|
|
US9987213B2
(en)
|
2012-06-13 |
2018-06-05 |
Edward Dunne Corboy, JR. |
Topical dihydrotestosterone (DHT) for promoting hair growth—containing formulations
|
|
WO2014081941A1
(en)
|
2012-11-21 |
2014-05-30 |
Topokine Therapeutics, Inc. |
Methods and compositions for locally increasing body fat
|
|
NO2753788T3
(https=)
|
2013-05-10 |
2018-06-16 |
|
|
|
WO2014186504A1
(en)
|
2013-05-15 |
2014-11-20 |
Topokine Therapeutics, Inc. |
Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
|
|
AU2014342811B2
(en)
|
2013-10-15 |
2019-01-03 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
WO2015200425A1
(en)
|
2014-06-27 |
2015-12-30 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
|
CN107921025A
(zh)
|
2015-03-08 |
2018-04-17 |
卡斯西部储备大学 |
用于治疗纤维症的短链脱氢酶活性的抑制剂
|
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
US20190275014A1
(en)
|
2016-07-18 |
2019-09-12 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for promoting neurogenesis and inhibiting cell death
|
|
EP3548035A4
(en)
|
2016-11-30 |
2020-07-22 |
Case Western Reserve University |
COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
|
|
JP2020514323A
(ja)
|
2017-02-06 |
2020-05-21 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物と方法
|
|
WO2018187810A1
(en)
|
2017-04-07 |
2018-10-11 |
Case Western Reserve University |
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
|
|
CA3058097C
(en)
|
2017-04-21 |
2024-01-02 |
Novaliq Gmbh |
Iodine compositions
|
|
WO2019068763A1
(en)
|
2017-10-04 |
2019-04-11 |
Novaliq Gmbh |
OPHTHALMIC COMPOSITIONS COMPRISING F6H8
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
KR102921276B1
(ko)
|
2018-11-21 |
2026-02-03 |
케이스 웨스턴 리저브 유니버시티 |
단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
|
|
FR3089413B1
(fr)
|
2018-12-06 |
2021-02-19 |
Fabre Pierre Dermo Cosmetique |
Extrait de Garcinia mangostana pour promouvoir la croissance capillaire
|
|
US20220249514A1
(en)
|
2019-06-28 |
2022-08-11 |
Regeus Limited Liability Company |
Remedy for hair growth enhancing
|
|
FR3099699B1
(fr)
|
2019-08-06 |
2025-09-26 |
Fabre Pierre Dermo Cosmetique |
Extrait d’akènes de Silybum marianum (L.) Gaertn. pour promouvoir la croissance capillaire
|
|
LT3886799T
(lt)
|
2019-08-07 |
2023-12-27 |
Aneira Pharma, Inc. |
Kompozicija, skirta plaukų slinkimo gydymui
|
|
US12539302B2
(en)
|
2019-08-07 |
2026-02-03 |
Aneira Pharma, Inc. |
Methods and compositions for the treatment of hair loss
|
|
JP2022543402A
(ja)
*
|
2019-08-09 |
2022-10-12 |
ノバリック ゲーエムベーハー |
プロスタグランジンアナログを含む局所組成物
|
|
EP3895685A1
(en)
|
2020-04-14 |
2021-10-20 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Natural composition for hair growth stimulation and hair loss prevention and treatment without preservatives
|
|
EP3895686B1
(en)
|
2020-04-14 |
2025-04-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Natural composition for hair growth stimulation and hair loss prevention and treatment
|
|
AU2021275122A1
(en)
|
2020-05-20 |
2022-12-15 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
JP7141025B1
(ja)
*
|
2021-11-11 |
2022-09-22 |
エルデシエロ プライベート リミテッド |
化合物、組成物、方法、及び製造方法
|
|
WO2026013128A1
(en)
|
2024-07-10 |
2026-01-15 |
Dermaliq Therapeutics, Inc. |
Treatment of androgenetic alopecia
|